CALL/MERCK & CO./130/0.1/21.06.24 | Real-time BOERSE MUENCHEN 03:56:52 03/06/2024 pm IST | ||
| 0.07 EUR | +11.11% |
|
| 1 month | -78.86% | ||
| 3 months | -84.86% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 0.07 | +11.11% |
| 31/24/31 | 0.063 | -38.24% |
| 30/24/30 | 0.102 | +61.90% |
| 29/24/29 | 0.063 | -7.35% |
| 28/24/28 | 0.068 | -60.92% |
Real-time BOERSE MUENCHEN
Last update June 03, 2024 at 03:56 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GK7054 |
| ISIN | DE000GK70543 |
| Date issued | 04/07/2022 |
| Strike | 130 $ |
| Maturity | 21/06/2024 (19 Days) |
| Parity | 10 : 1 |
| Emission price | 0.22 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.935 € |
|---|---|
| Lowest since issue | 0.029 € |
| Spread | 0.03 € |
| Spread % | 33.33% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Warrants
- Warrant
